Stocktoria
Iterum Therapeutics plc ITRMF
OTC · stock · Pharmaceutical Preparations · website · IPO 2018-05-25
Iterum Therapeutics plc statistics & valuation
Market cap$2.6M
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | -275732.4% | -8810.0% | -5798.2% |
| Net margin | — | — | — | — | — | -278729.7% | -8867.2% | -5788.6% |
| FCF margin | — | — | — | — | — | -221475.7% | -8900.1% | -6184.3% |
| Return on assets | -55.6% | -146.1% | -66.5% | -100.1% | -158.6% | -400.5% | -78.7% | -62.9% |
| Return on equity | 607.1% | 599.3% | -158.7% | -182.3% | 102.9% | 393.1% | -107.6% | -74.5% |
| Debt / equity | -7.65× | -1.79× | 0.45× | 0.14× | -0.44× | -0.29× | 0.18× | 0.00× |
| Current ratio | 1.41 | 1.89 | 6.89 | 6.43 | 0.51 | 0.32 | 7.61 | 6.20 |
Source: SEC EDGAR filings · CIK 0001659323 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.